The purpose of this study is to evaluate the safety, feasibility and outcome of administering three different statins at submaximal and maximal dose on early cognitive dysfunction (eCD) and delayed cognitive dysfunction (dCD).
|Effective start/end date||7/1/18 → 11/30/22|
- Columbia University (10(GG011968-01)//5R01AG050819-02)
- National Institute on Aging (10(GG011968-01)//5R01AG050819-02)
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.